Dihydroxy zanubrutinib

SL-9183

Dihydroxy zanubrutinib, >98%

IUPAC Name : 7-(1-(2,3-Dihydroxypropanoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a impurity / metabolite of Zanubrutinib, which is a potent, specific and irreversible BTK inhibitor that has been shown to have a lower off-target inhibitory activity on other kinases, including ITK, JAK3 and EGFR. Zanubrutinib is used to treat mantle cell lymphoma.

References : Tam C. et al.: Blood 126, 832, 2015; Li N. et al.: AACR Cancer Res., 75(15 Suppl), Abstract nr 2597, 2015; Wu J. et al.: J. Hematol Oncol., 9(1), 80, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.